ZUMA‐24: A phase 2, open-label study of axicabtagene ciloleucel in patients with relapsed/refractory large B‐cell lymphoma given outpatient with corticosteroids Meeting Abstract
| Authors: | Leslie, L.; Tees, M.; Flinn, I. W.; Rodriguez, T. E.; Baird, J. H.; Deol, A.; Mead, M.; Bachier, C.; Rapoport, A. P.; McClune, B.; Hoda, D.; Perales, M.; Zheng, Y.; Filosto, S.; Davis, M.; Miao, H.; Kim, J. J.; Oluwole, O. O. |
| Abstract Title: | ZUMA‐24: A phase 2, open-label study of axicabtagene ciloleucel in patients with relapsed/refractory large B‐cell lymphoma given outpatient with corticosteroids |
| Meeting Title: | 17th International Conference on Malignant Lymphoma (ICML) |
| Journal Title: | Hematological Oncology |
| Volume: | 41 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Jun 13-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2023-06-01 |
| Start Page: | 843 |
| End Page: | 845 |
| Language: | English |
| DOI: | 10.1002/hon.3166_OT23 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: OT23 -- Source: Cinahl |
